CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 1 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,610,000 | – | 100,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,425,225 | $116,241,000 | 1.40% |
| NEA Management Company, LLC | 2,141,697 | $23,880,000 | 1.03% |
| Birchview Capital, LP | 122,000 | $1,360,000 | 0.88% |
| Opaleye Management Inc. | 148,832 | $1,660,000 | 0.42% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 816,981 | $9,109,000 | 0.28% |
| Artal Group S.A. | 692,000 | $7,716,000 | 0.20% |
| SECTORAL ASSET MANAGEMENT INC | 123,405 | $1,376,000 | 0.15% |
| Baker Brothers Advisors | 1,933,624 | $21,560,000 | 0.14% |
| Rock Springs Capital Management LP | 345,000 | $3,847,000 | 0.14% |
| PFM Health Sciences, LP | 322,732 | $3,598,000 | 0.05% |